DNA methylation patterns-based subtype distinction and identification of soft tissue sarcoma prognosis

Area of Science:

• Oncology
• Genomics
• Epigenetics

Background:

• Soft tissue sarcomas (STSs) exhibit clinical heterogeneity and variable aggressiveness.
• Accurate prognostic subtyping is crucial for effective treatment strategies.

Purpose of the Study:

• To establish a DNA methylation-based classification for soft tissue sarcomas (STSs).
• To identify distinct prognostic subtypes within STSs.
• To develop a predictive model for patient survival.

Main Methods:

• Utilized DNA methylation data from The Cancer Genome Atlas (TCGA) database.
• Applied clustering algorithms to stratify STSs samples into subgroups.
• Conducted Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
• Developed a prognostic risk signature using LASSO and selection operator algorithms.
• Constructed a nomogram integrating clinical features and risk score for survival prediction.

Main Results:

• STSs samples were classified into four distinct molecular subtypes with significantly different survival curves.
• Each subtype displayed differential clinical features.
• Pathway analysis revealed enrichment in cancer-associated biological functions and pathways.
• The developed risk signature demonstrated strong performance in risk stratification for STSs patients.

Conclusions:

• DNA methylation-based subtyping provides a robust method for classifying STSs.
• This classification offers valuable prognostic prediction for STSs patients.
• The findings support the development of personalized therapeutic approaches for STSs.